MCRB: Seres Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Seres Therapeutics Inc (MCRB).
$141.88M Market Cap.
MCRB Market Cap. (MRY)
MCRB Shares Outstanding (MRY)
MCRB Assets (MRY)
Total Assets
$139.81M
Total Liabilities
$126.03M
Total Investments
$0
MCRB Income (MRY)
Revenue
$0
Net Income
$136.00K
Operating Expense
$121.31M
MCRB Cash Flow (MRY)
CF Operations
-$148.61M
CF Investing
$142.29M
CF Financing
-$90.37M
MCRB Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $139,810,000 (-61.01%) | $358,600,000 (2.81%) | $348,784,000 (-1.71%) | $354,859,000 (3.48%) |
Assets Current | $38,674,000 (-77.95%) | $175,410,000 (-9.94%) | $194,764,000 (-35.85%) | $303,628,000 (12.97%) |
Assets Non-Current | $101,136,000 (-44.79%) | $183,190,000 (18.94%) | $154,020,000 (200.64%) | $51,231,000 (-30.92%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $13,784,000 (130.73%) | -$44,856,000 (-515.99%) | $10,783,000 (-91.80%) | $131,507,000 (-24.75%) |
Property Plant & Equipment Net | $92,437,000 (-30.10%) | $132,250,000 (-1.28%) | $133,969,000 (270.63%) | $36,146,000 (57.58%) |
Cash & Equivalents | $39,461,000 (-71.02%) | $136,150,000 (-20.48%) | $171,215,000 (-8.93%) | $188,002,000 (62.00%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | -$12,000 (80.00%) | -$60,000 (-27.66%) |
Deferred Revenue | $0 (0%) | $103,094,000 (6.62%) | $96,689,000 (-6.87%) | $103,817,000 (-4.03%) |
Total Investments | $0 (0%) | $1,401,000 (-92.89%) | $19,712,000 (-82.49%) | $112,600,000 (-40.36%) |
Investments Current | $0 (0%) | $0 (0%) | $18,311,000 (-83.46%) | $110,704,000 (-19.53%) |
Investments Non-Current | $0 (0%) | $1,401,000 (0.00%) | $1,401,000 (-26.11%) | $1,896,000 (-96.30%) |
Inventory | $0 (0%) | $29,647,000 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $2,068,000 (-76.16%) | $8,674,000 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $4,079,000 (12.03%) | $3,641,000 (-79.12%) | $17,440,000 (26.97%) | $13,735,000 (241.84%) |
Accumulated Retained Earnings (Deficit) | -$978,099,000 (0.01%) | -$978,235,000 (-13.15%) | -$864,511,000 (-40.72%) | -$614,354,000 (-11.95%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $91,640,000 (-57.16%) | $213,936,000 (31.58%) | $162,590,000 (230.39%) | $49,211,000 (20.71%) |
Debt Current | $8,674,000 (29.91%) | $6,677,000 (64.58%) | $4,057,000 (-38.62%) | $6,610,000 (18.69%) |
Debt Non-Current | $82,966,000 (-59.97%) | $207,259,000 (30.74%) | $158,533,000 (272.13%) | $42,601,000 (21.03%) |
Total Liabilities | $126,026,000 (-68.76%) | $403,456,000 (19.37%) | $338,001,000 (51.33%) | $223,352,000 (32.80%) |
Liabilities Current | $41,222,000 (-58.22%) | $98,659,000 (15.26%) | $85,596,000 (4.06%) | $82,258,000 (77.22%) |
Liabilities Non-Current | $84,804,000 (-72.18%) | $304,797,000 (20.76%) | $252,405,000 (78.89%) | $141,094,000 (15.86%) |
MCRB Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $126,325,000 (1672.24%) | $7,128,000 (-95.08%) | $144,927,000 (336.33%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $53,183,000 (-39.39%) | $87,744,000 (10.10%) | $79,694,000 (15.06%) | $69,261,000 (125.06%) |
Research & Development Expense | $64,600,000 (-55.71%) | $145,860,000 (-15.65%) | $172,920,000 (21.87%) | $141,891,000 (56.66%) |
Operating Expenses | $121,315,000 (-48.22%) | $234,308,000 (-7.61%) | $253,618,000 (21.10%) | $209,420,000 (72.58%) |
Interest Expense | $0 (0%) | $13,176,000 (118.87%) | $6,020,000 (106.87%) | $2,910,000 (-0.48%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | -$125,907,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | $136,000 (100.12%) | -$113,724,000 (54.54%) | -$250,157,000 (-281.46%) | -$65,578,000 (26.42%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | $136,000 (100.12%) | -$113,724,000 (54.54%) | -$250,157,000 (-281.46%) | -$65,578,000 (26.42%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | $136,000 (100.12%) | -$113,724,000 (54.54%) | -$250,157,000 (-281.46%) | -$65,578,000 (26.42%) |
Weighted Average Shares | $155,400,760 (21.40%) | $128,003,294 (18.44%) | $108,077,043 (17.86%) | $91,702,866 (14.93%) |
Weighted Average Shares Diluted | $155,400,760 (21.40%) | $128,003,294 (18.44%) | $108,077,043 (17.86%) | $91,702,866 (14.93%) |
Earning Before Interest & Taxes (EBIT) | $136,000 (100.14%) | -$100,548,000 (58.81%) | -$244,137,000 (-289.57%) | -$62,668,000 (27.30%) |
Gross Profit | $0 (0%) | $126,325,000 (1672.24%) | $7,128,000 (-95.08%) | $144,927,000 (336.33%) |
Operating Income | -$121,315,000 (-12.35%) | -$107,983,000 (56.19%) | -$246,490,000 (-282.20%) | -$64,493,000 (26.82%) |
MCRB Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $142,293,000 (1244.67%) | $10,582,000 (-87.16%) | $82,428,000 (28.62%) | $64,088,000 (140.33%) |
Net Cash Flow from Financing | -$90,372,000 (-226.03%) | $71,705,000 (-44.67%) | $129,602,000 (10901.87%) | $1,178,000 (-99.61%) |
Net Cash Flow from Operations | -$148,609,000 (-26.63%) | -$117,354,000 (48.71%) | -$228,816,000 (-3521.29%) | $6,688,000 (107.14%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$96,688,000 (-175.72%) | -$35,067,000 (-108.91%) | -$16,786,000 (-123.33%) | $71,954,000 (41.30%) |
Net Cash Flow - Business Acquisitions and Disposals | $141,272,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $1,401,000 (-92.45%) | $18,557,000 (-79.88%) | $92,249,000 (25.25%) | $73,654,000 (146.53%) |
Capital Expenditure | -$380,000 (95.24%) | -$7,975,000 (18.80%) | -$9,821,000 (-2.67%) | -$9,566,000 (-1518.61%) |
Issuance (Repayment) of Debt Securities | -$127,905,000 (-353.19%) | $50,518,000 (96.58%) | $25,699,000 (2810.86%) | -$948,000 (0%) |
Issuance (Purchase) of Equity Shares | $37,533,000 (77.15%) | $21,187,000 (-79.61%) | $103,903,000 (4787.25%) | $2,126,000 (-99.30%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$1,000 (-150.00%) | $2,000 (300.00%) | -$1,000 (0.00%) | -$1,000 (0%) |
Share Based Compensation | $20,971,000 (-38.50%) | $34,101,000 (33.82%) | $25,482,000 (26.01%) | $20,222,000 (129.17%) |
Depreciation Amortization & Accretion | $14,698,000 (-2.75%) | $15,114,000 (27.51%) | $11,853,000 (28.53%) | $9,222,000 (3.70%) |
MCRB Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) |
Profit Margin | - | -90.00% (97.44%) | -3509.50% (-7664.38%) | -45.20% (83.15%) |
EBITDA Margin | - | -67.60% (97.93%) | -3258.80% (-8731.44%) | -36.90% (84.15%) |
Return on Average Equity (ROAE) | -0.50% (-100.09%) | 533.70% (197.28%) | -548.60% (-1054.95%) | -47.50% (68.61%) |
Return on Average Assets (ROAA) | 0.10% (100.31%) | -32.40% (59.40%) | -79.80% (-303.03%) | -19.80% (49.49%) |
Return on Sales (ROS) | - | -79.60% (97.68%) | -3425.00% (-7828.24%) | -43.20% (83.35%) |
Return on Invested Capital (ROIC) | 0.10% (100.31%) | -32.70% (79.00%) | -155.70% (-314.10%) | -37.60% (49.93%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | - | -1.57 (35.11%) | -2.42 (79.05%) | -11.57 (47.11%) |
Price to Sales Ratio (P/S) | - | 1.42 (-98.33%) | 84.91 (1510.87%) | 5.27 (-91.04%) |
Price to Book Ratio (P/B) | 10.29 (355.16%) | -4.03 (-106.23%) | 64.7 (1012.15%) | 5.82 (-54.52%) |
Debt to Equity Ratio (D/E) | 9.14 (201.66%) | -8.99 (-128.69%) | 31.35 (1746.05%) | 1.7 (76.51%) |
Earnings Per Share (EPS) | 0 (0%) | -0.89 (61.47%) | -2.31 (-220.83%) | -0.72 (35.71%) |
Sales Per Share (SPS) | 0 (0%) | 0.99 (1395.45%) | 0.07 (-95.82%) | 1.58 (279.81%) |
Free Cash Flow Per Share (FCFPS) | -0.96 (2.04%) | -0.98 (55.66%) | -2.21 (-7022.58%) | -0.03 (97.38%) |
Book Value Per Share (BVPS) | 0.09 (125.43%) | -0.35 (-450.00%) | 0.1 (-93.03%) | 1.43 (-34.52%) |
Tangible Assets Book Value Per Share (TABVPS) | 0.9 (-67.87%) | 2.8 (-13.20%) | 3.23 (-16.61%) | 3.87 (-9.96%) |
Enterprise Value Over EBIT (EV/EBIT) | 1,168 (58500.00%) | -2 (0.00%) | -2 (77.78%) | -9 (62.50%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 10.71 (525.14%) | -2.52 (-4.39%) | -2.41 (77.83%) | -10.88 (59.37%) |
Asset Turnover | 0 (0%) | 0.36 (1465.22%) | 0.02 (-94.74%) | 0.44 (199.32%) |
Current Ratio | 0.94 (-47.24%) | 1.78 (-21.85%) | 2.27 (-38.36%) | 3.69 (-36.26%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$148,989,000 (-18.88%) | -$125,329,000 (47.48%) | -$238,637,000 (-8191.77%) | -$2,878,000 (96.94%) |
Enterprise Value (EV) | $158,798,335 (-26.19%) | $215,141,079 (-61.59%) | $560,170,750 (-3.65%) | $581,418,651 (-71.91%) |
Earnings Before Tax (EBT) | $136,000 (100.12%) | -$113,724,000 (54.54%) | -$250,157,000 (-281.46%) | -$65,578,000 (26.42%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $14,834,000 (117.36%) | -$85,434,000 (63.22%) | -$232,284,000 (-334.61%) | -$53,446,000 (30.87%) |
Invested Capital | $150,767,000 (-55.36%) | $337,727,000 (32.67%) | $254,563,000 (90.24%) | $133,810,000 (-39.52%) |
Working Capital | -$2,548,000 (-103.32%) | $76,751,000 (-29.69%) | $109,168,000 (-50.69%) | $221,370,000 (-0.45%) |
Tangible Asset Value | $139,810,000 (-61.01%) | $358,600,000 (2.81%) | $348,784,000 (-1.71%) | $354,859,000 (3.48%) |
Market Capitalization | $141,883,335 (-21.59%) | $180,960,079 (-74.06%) | $697,713,750 (-8.81%) | $765,086,651 (-65.78%) |
Average Equity | -$27,277,250 (-28.01%) | -$21,309,000 (-146.73%) | $45,595,500 (-66.96%) | $138,004,000 (134.32%) |
Average Assets | $245,386,250 (-30.03%) | $350,720,000 (11.90%) | $313,434,250 (-5.48%) | $331,623,750 (45.70%) |
Invested Capital Average | $240,978,250 (-21.64%) | $307,536,000 (96.13%) | $156,802,500 (-5.98%) | $166,768,750 (45.22%) |
Shares | 170,738,069 (32.09%) | 129,257,199 (3.74%) | 124,591,741 (35.65%) | 91,847,137 (0.66%) |
